Skye Bioscience, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
NV
Business Address
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
Mailing Address
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
Phone
(858) 410-0266
Fiscal Year End
1231
EIN
450692882
Financial Overview
FY2025
$72.76M
Total Assets
$8.29M
Total Liabilities
$-0.73
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 8-K Current report of material events | March 19, 2026 | View on SEC |
| 10-K Annual financial report | March 10, 2026 | View on SEC |
Annual Reports
10-K
March 10, 2026
- Lead drug candidate SBI-100 Ophthalmic Emulsion for glaucoma completed Phase 2 enrollment on schedule by Q3 2025.
- Secured a key European Union patent covering the formulation and use of SBI-100, strengthening intellectual property.
Material Events
8-K
Financial Distress
March 19, 2026
High Impact
- Skye Bioscience is developing new cannabinoid-based medicines for serious conditions like glaucoma and metabolic disorders.
- The company has a 180-day window (until September 14, 2026) to regain Nasdaq compliance by increasing its stock price.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.